Compound information
- Natural Products
- ZC746345
- Molecular Formula
- C24H31N5O5
- Molecular Weight
- 469.232519092 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-[[(2S)-2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-5-guanidino-pentanoate
- InChI
- InChI=1S/C24H31N5O5/c1-33-22(31)19(13-8-14-27-23(25)26)28-21(30)20(15-17-9-4-2-5-10-17)29-24(32)34-16-18-11-6-3-7-12-18/h2-7,9-12,19-20H,8,13-16H2,1H3,(H,28,30)(H,29,32)(H4,25,26,27)/t19-,20-/m0/s1
- InChI Key
- DBBGYDMATYKUOH-PMACEKPBSA-N
- SMILES
- COC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1
- Source
- ZINC000015722056
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 155.63 Å2 | LogP | 1.69 |
LogS | -3.054 | LogD | 1.826 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.012 | Pgp substrate | 0.957 |
HIA | 0.206 | F20 % | 0.345 |
F30 % | 0.0 | Caco-2 | -5.755 |
MDCK | -5.156 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.025 | PPB | 80.666 |
VD | 1.144 | Fu | 0.7 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.673 |
CYP2A6 substrate | 0.512 | CYP2B6 substrate | 0.528 |
CYP2C19 inhibitor | 0.195 | CYP2C19 substrate | 0.919 |
CYP2C8 substrate | 0.717 | CYP2C9 inhibitor | 0.078 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.196 |
CYP2D6 substrate | 0.946 | CYP2E1 substrate | 0.304 |
CYP3A4 inhibitor | 0.062 | CYP3A4 substrate | 0.984 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.677 | CL | 3.46 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.591 | Hepatotoxicity | 0.13 |
Mutagenicity | 0.043 | Rat Oral Acute Toxicity | 0.216 |
FDAMDD | 0.74 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.005 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.156 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.686 | IGC50 | 3.667 |
LC50FM | 3.171 | LC50DM | 3.269 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.155 | NR-AR-LBD | 0.212 |
NR-AhR | 0.003 | NR-Aromatase | 0.03 |
NR-ER | 0.269 | NR-ER-LBD | 0.387 |
NR-PPAR-gamma | 0.3 | SR-ARE | 0.123 |
SR-ATAD5 | 0.43 | SR-HSE | 0.305 |
SR-MMP | 0.067 | SR-p53 | 0.042 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.